West Pharmaceutical CEO Donald Morel Intends To Retire, Revises FY14 EPS View

(RTTNews) - West Pharmaceutical Services, Inc. (WST) on Wednesday said its Chief Executive Officer and Chairman Donald Morel has plans to retire in May 2015. The company shall start a comprehensive search for replacement. In addition, the company narrowed its full-year adjusted earnings per share guidance to a range of $1.77 to $1.82, from the previous range of $1.77 to $1.89, primarily due to the foreign currency translation from the strengthening of the dollar and tax-rate changes attributed to the geographic mix of earnings. For the third-quarter the group expects earnings to be $0.43 per share, including a $0.01 per-share charge for in-process research.